Skip to content
HowShorted

OCULAR THERAPEUTIX, INC short interest in 2022

In 2022, OCULAR THERAPEUTIX, INC's disclosed short interest ran from 4.15% of shares outstanding on 14 Jan 2022 to 3.86% on 30 Dec 2022, a change of -0.29 percentage points. The year's high was 6.08% on 28 Feb 2022 and its low 3.78% on 15 Sep 2022, averaging 4.59% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.41 days on 29 Jul 2022. Full history: OCULAR THERAPEUTIX, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for OCULAR THERAPEUTIX, INC in 2022

2022 in figures

Start of year
4.15% (14 Jan 2022)
End of year
3.86% (30 Dec 2022)
Change
-0.29 pp
High
6.08% (28 Feb 2022)
Low
3.78% (15 Sep 2022)
Average
4.59%
Highest days to cover
9.41 (29 Jul 2022)
SEC filings marked
8

Every report in 2022

OCULAR THERAPEUTIX, INC short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20224.15%5.70
31 Jan 20224.38%4.96
15 Feb 20225.06%6.64
28 Feb 20226.08%6.4410-K filed, results (8-K)
15 Mar 20226.04%8.66
31 Mar 20225.46%7.93
14 Apr 20225.24%7.12
29 Apr 20225.22%5.52
13 May 20225.10%3.3910-Q filed, results (8-K)
31 May 20225.15%5.45
15 Jun 20224.57%5.39
30 Jun 20224.40%5.70
15 Jul 20224.55%8.59
29 Jul 20224.48%9.41
15 Aug 20224.36%4.9110-Q filed, results (8-K)
31 Aug 20224.29%7.33
15 Sep 20223.78%3.99
30 Sep 20223.87%1.76
14 Oct 20224.24%3.67
31 Oct 20224.33%4.94
15 Nov 20223.80%3.8310-Q filed, results (8-K)
30 Nov 20223.80%6.45
15 Dec 20223.94%4.88
30 Dec 20223.86%4.40

See also: OCULAR THERAPEUTIX, INC's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.